Keyphrases
Breast Cancer
75%
Toll-like
45%
Breast Cancer Patients
40%
Prognostic Factors
37%
Tumor
36%
Triple-negative Breast Cancer
32%
Statins
30%
Type III Collagen
27%
Confidence Interval
26%
Hazard Ratio
26%
Antidiabetic Drugs
25%
Early Breast Cancer
24%
Type III Procollagen
24%
Type I Collagen
24%
Breast Cancer Survival
23%
Metformin
21%
Radiotherapy
21%
Type I Procollagen
21%
Propeptide
21%
Overall Survival
20%
Type 2 Diabetic Patients
20%
Patients with Breast Cancer
16%
Retrospective Cohort Study
15%
Disease-free Survival
15%
Breast Cancer Risk
15%
Finland
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Prognostic Value
15%
Cancer Inpatients
15%
Single Center
15%
Capecitabine
13%
Patient Survival
13%
Collagen
12%
Procollagen
12%
Collagen Synthesis
12%
Breast Carcinoma
12%
Metastatic Breast Cancer
11%
Triple Negative
11%
Cyclophosphamide
11%
Recurrence-free Survival
11%
Epirubicin
11%
University Hospital
11%
Breast Cancer Cases
11%
Suction Blister
11%
Basal-like
10%
Adjuvant Capecitabine
10%
Breast Carcinogenesis
10%
Number of Patients
10%
Human Skin
10%
Estrogen Therapy
10%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
33%
Prognostic Factor
32%
Triple Negative Breast Cancer
30%
Breast Carcinoma
26%
Toll Like Receptor 9
25%
Radiation Therapy
23%
Collagen Type 1
17%
Statin
17%
Metastatic Carcinoma
16%
Disease Free Survival
16%
Estrogen Receptor
16%
Overall Survival
16%
Hazard Ratio
16%
Mantle Cell Lymphoma
15%
Diseases
15%
Maturity Onset Diabetes of the Young
12%
Glycon
12%
Recurrent Disease
12%
Collagen Synthesis
12%
Collagen Type 3
11%
Metastatic Breast Cancer
11%
Antiestrogen
10%
Lung Metastasis
10%
Retrospective Cohort Study
10%
Patient with Type 2 Diabetes
10%
Zoledronic Acid
9%
Procollagen
8%
Breast Tumor
8%
Cancer Cell
7%
Distant Metastasis
7%
Cancer Diagnosis
7%
Patient Population
7%
Cohort Analysis
7%
Cancer Specific Survival
7%
Hormone Receptor
7%
Vimentin
7%
Bisphosphonate
7%
Prostate Cancer
6%
Progression Free Survival
6%
Blister Fluid
6%
Ductal Carcinoma
6%
In Vitro
6%
Hypoxia
6%
Gene Expression
6%
Basal Like Breast Cancer
6%
Adjuvant Therapy
6%
Recurrence Free Survival
6%
Cytarabine
5%
Prospective Cohort Study
5%
Biochemistry, Genetics and Molecular Biology
TLR9
30%
Statin
30%
Cohort Study
27%
Cancer Cell
22%
Overall Survival
17%
Estrogen Receptor
16%
Type I Collagen
15%
Fibroblast
15%
Capecitabine
15%
Allele
13%
Disease Free Survival
12%
Cancer Specific Survival
11%
Cyclophosphamide
11%
Epirubicin
11%
Hormone Receptor
10%
Mobile Application
10%
Missense Mutation
10%
Synapsin I
10%
Cancer Survival
10%
Recurrence Free Survival
9%
Transcription Factors
7%
DNA Repair
7%
Liquid
7%
Messenger RNA
7%
Small Hairpin RNA
6%
Progression Free Survival
6%
Multivariate Analysis
6%
Gene Mutation
6%
Oxidative Stress
6%
Vimentin
6%
Time-of-Flight Mass Spectrometry
6%
Angiogenesis
6%
Genomics
6%
Vitamin C
6%
Cancer Staging
6%
Progesterone Receptor
6%
Genotyping
5%
Cancer Mortality
5%
Macrophage
5%
Blood Level
5%
Survival Rate
5%
N-Terminus
5%
Immunity
5%
Carcinogenesis
5%
Epidermal Growth Factor Receptor
5%
Fluorouracil
5%
P16
5%
Tyrosine
5%
Serum (Blood)
5%
Sulfate
5%
